Hengkang Historical Cash Flow
| 002219 Stock | 2.48 0.03 1.20% |
Analysis of Hengkang Medical cash flow over time is an excellent tool to project Hengkang Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Income of 29.1 M or Dividends Paid of 100.9 M as it is a great indicator of Hengkang Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Hengkang Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hengkang Medical is a good buy for the upcoming year.
Hengkang |
About Hengkang Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Hengkang balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Hengkang's non-liquid assets can be easily converted into cash.
Hengkang Medical Cash Flow Chart
Add Fundamental
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Hengkang Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Hengkang Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Hengkang Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, Hengkang Medical's Net Income is projected to decrease significantly based on the last few years of reporting. The current year's Total Cash From Operating Activities is expected to grow to about 351.4 M, whereas Capital Expenditures is forecasted to decline to about 160.6 M.
Hengkang Medical cash flow statement Correlations
Click cells to compare fundamentals
Hengkang Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hengkang Medical cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Capital Expenditures | 216.6M | 198.7M | 221.6M | 195.2M | 224.4M | 160.6M | |
| Net Income | (52.2M) | (371.4M) | 155.6M | 30.8M | 27.7M | 29.1M | |
| Dividends Paid | 83.9M | 54.2M | 275.8M | 104.0M | 119.6M | 100.9M | |
| Total Cash From Operating Activities | 283.8M | 277.3M | 268.0M | 291.0M | 334.6M | 351.4M | |
| Change To Account Receivables | 30.0M | 761.4M | (14.1M) | (70.2M) | (80.8M) | (84.8M) | |
| Total Cash From Financing Activities | (585.6M) | (174.7M) | 1.8B | (1.5B) | (1.4B) | (1.3B) | |
| Change To Inventory | (23.5M) | (7.3M) | 20.8M | (52.3M) | (60.1M) | (57.1M) | |
| Other Cashflows From Financing Activities | 40.6M | (39.0M) | (19.6M) | (82.7K) | (95.1K) | (90.3K) | |
| Investments | (217.7K) | (1M) | 1M | (335.1M) | (301.6M) | (286.5M) | |
| Change In Cash | 32.1M | 1.8B | (1.5B) | 18.7M | 21.5M | 22.5M | |
| Net Borrowings | (151.7M) | (71.2M) | 30.0M | (1.3B) | (1.1B) | (1.1B) | |
| Total Cashflows From Investing Activities | (276.0M) | (77.1M) | (199.1M) | (192.3M) | (221.2M) | (232.2M) | |
| Depreciation | 170.7M | 163.3M | 155.6M | 217.2M | 249.8M | 188.4M | |
| End Period Cash Flow | 143.4M | 2.0B | 537.9M | 557.0M | 640.6M | 624.1M | |
| Change To Netincome | 2.6B | 123.9M | 499.5M | 132.9M | 119.6M | 113.6M | |
| Change To Liabilities | (464.8M) | 69.6M | 48.7M | (19.4M) | (17.5M) | (18.3M) | |
| Free Cash Flow | 67.2M | 78.6M | 46.5M | 95.8M | 110.2M | 115.7M | |
| Change In Working Capital | 24.4M | (28.8M) | (205.7M) | (207.0M) | (238.0M) | (226.1M) | |
| Begin Period Cash Flow | 111.3M | 143.4M | 2.0B | 538.3M | 619.1M | 625.8M | |
| Other Non Cash Items | 146.0M | 244.8M | 161.3M | 142.1M | 127.9M | 190.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Hengkang Stock
The Cash Flow Statement is a financial statement that shows how changes in Hengkang balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Hengkang's non-liquid assets can be easily converted into cash.